Clinical trial

Antiretroviral Regime for Viral Eradication in Newborns

NCT02712801

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-04-01

PhasePHASE4

Study timeline

Study start (actual)2016-04-01Date precision: month

Registry last updated2022-09-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV/AIDS and Infectionsunresolved

Interventions

ZidovudineDRUG · verified · RxNorm: zidovudine

NevirapineDRUG · verified · RxNorm: nevirapine

LamivudineDRUG · verified · RxNorm: lamivudine

Lopinavir/ritonavirDRUG

Sponsors & collaborators

National Center for Women and Children's Health, China CDClead sponsor

National Center for AIDS/STD Control and Prevention, China CDCcollaborator

Maternal and Child Health Hospital of Yunan Provincecollaborator

Maternal and Child Health Hospital of Sichuan Provincecollaborator

Maternal and Child Health Hospital of Guangxi Provincecollaborator

Maternal and Child Health Hospital of Xinjiang Uygur Autonomous Regioncollaborator

Guangdong Provincial Maternal and Child Health Hospitalcollaborator

Mapped research locations

GuangzhouGuangdong, China1 ChengduSichuan, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02712801 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.